This site is intended for healthcare professionals only
LoginRegister
West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions ContinueWest Pharma Raises 2024 Profit Forecast Amid Surging Demand for Injectable Therapy Supplies
Mylan Laboratories Gets CDSCO Nod to Manufacture and Market Epinephrine tartrate InjectionMylan Laboratories Gets CDSCO Nod to Manufacture and Market Epinephrine tartrate Injection
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJohnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab
Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges TerminationNo violation of Abbott's trademark: Delhi HC upholds trademark of Mebufen against Brufen
Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye DevicePhilips, Medtronic Ink Advocacy Partnership to Enhance Stroke Care Access
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics
Rhythm Pharma, Axovia Therapeutics Launch Joint Research Collaboration for Bardet-Biedl SyndromeRhythm Pharma, Axovia Therapeutics Launch Joint Research Collaboration for Bardet-Biedl Syndrome
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck's KEYTRUDA Gains European Approval for Two New Gynecologic Cancer Treatments
Bayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart diseaseBayer, Dewpoint ink USD 424 million deal to develop breakthrough therapy for genetic heart disease
Health Ministry Moves to Simplify Ethics Committee Registration Under NDCT RulesMarinus Pharma Halts Development After Seizure Drug Fails Trial
Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human ResourcesStrides Pharma Posts Record Q2 Growth with Rs 12,011 Million Revenue, Highest Ever US Sales
Insulin Tablets banned, License of pharma firm cancelled after activist flags mislabeling risks for diabetics'Insulin Tablets' banned, License of pharma firm cancelled after activist flags mislabeling risks...
X